On the 28th, Andon Health Co.Ltd(002432) replied to the letter of concern from Shenzhen Stock Exchange, and replied to questions such as “the company believes that the kit can detect the Omicron mutant strain” and “the kit products rank first in Amazon’s sales in the United States”.
Andon Health Co.Ltd(002432) said that for New Coronavirus’s “Omicron” mutant strain found in South Africa, to ensure the effectiveness of the detection of the virus by the company’s antigenic kit, it is necessary to confirm the results of the bioinformatics comparison, the recombinant N protein comparison test and the actual virus test performance test three. At present, the company has completed the comparative test of recombinant N protein with and without Omicron mutation through a third-party laboratory. There is basically no difference in the test results between the two. Theoretically, it can be inferred that the effectiveness of the company’s kit products in detecting Omicron virus. However, for the sake of scientific prudence, the product will be verified by test performance experiments after obtaining the virus strain, Confirm the effectiveness of the product for detecting the virus strain. The company will officially announce after the experiment is completed and the Omicron mutant virus can be tested.
In addition, on the question of ranking first in the sales of kit products on Amazon’s U.S. website, Andon Health Co.Ltd(002432) said that Amazon’s official U.S. platform counted the sales of each product and published the comprehensive ranking based on the combination of daily sales and instantaneous sales in real time. However, Amazon platform does not publish sales and sales in any form, nor can it infer relevant data from this ranking. In the past interactive Q & A, the company has never released information about the sales and sales of kit products. Andon Health Co.Ltd(002432) pointed out that in the previous Q & a reply of interactive easy platform, the company’s ihealth kit product sales ranked first. However, the sales ranking of Amazon USA is a comprehensive ranking based on the combination of daily sales and instantaneous sales, and the ranking will be updated in real time, which does not represent the cumulative sales. According to the query results on December 28, the sales of the company’s kit products on Amazon USA platform ranks No. 6.
In response to the letter of concern from Shenzhen Stock Exchange, Andon Health Co.Ltd(002432) also mentioned that the company currently fully supports the epidemic prevention work of the governments of various states in the United States. As of December 27, us time, the company had received 47.43 million government orders from Massachusetts, California, New York, Washington, D.C., Washington, Louisiana, Maryland and Oregon, At present, 8.82 million copies have been shipped, US $62.55 million (including advance payment) has been received, and the amount of orders that have not been received is US $174.6 million. The sales collection amount of commercial customers is USD 36.19 million, and the sales amount of the company’s website and Amazon in the United States is USD 68.35 million. However, the purchase amount of a single customer did not reach 50% (RMB 1.004 billion) of the latest audited sales revenue, so no announcement was made.
According to the third quarterly report of 2021 disclosed by Andon Health Co.Ltd(002432) , the company’s revenue in the first three quarters was 790 million yuan, a year-on-year decrease of 50.82%; The net profit was 50.1280 million yuan, a year-on-year decrease of 86.19%. According to the amount of government orders received by various states in the United States, the amount of sales remittances from commercial customers, the website and Amazon’s sales in the United States disclosed by the company above, the total revenue of these three items has reached US $167.09 million. Calculated at the central parity of RMB against the US dollar on December 28, the company’s recent revenue in the detection box business has reached RMB 1.065 billion; If we add the amount of uncollected orders from US governments, the company’s revenue has reached RMB 2.178 billion.
Previously, on November 15, Andon Health Co.Ltd(002432) said on the interactive platform that the company’s covid-19 antigen home self-test OTC kit products had begun mass production, and had been sold in local spot by ihealth in the United States at the beginning of last week. At the same time, the company was also actively negotiating orders with b-end customers and demand parties. The company’s current monthly production capacity is 100 million people, and it is estimated that by the beginning of 2022, The production capacity will be increased to 200 million people per month, and the actual production capacity expansion progress and production plan will be adjusted in real time according to the actual situation of the market, orders, raw material supply and so on.
Source: Investor interaction platform
Subsequently, Andon Health Co.Ltd(002432) share price started the soaring mode. From the first trading limit on November 15 to closing at 45.50 yuan / share on December 28, Andon Health Co.Ltd(002432) 32 trading days increased by nearly 570%.
Andon Health Co.Ltd(002432) in the attention letter, it also reminded the risk that from the technical indicators of the secondary market, the company’s dynamic P / E ratio was 303 as of December 27; In terms of price to book ratio, as of the closing on December 27, the company’s share price in the secondary market was 42.37 yuan / share, and the company’s price to book ratio was 10.11. At present, the above data of the company are higher than the company’s historical share price and P / E ratio. In addition, there are uncertain risks in the development of epidemic situation and market competition in the United States.
(Zhongxin Jingwei)
